2012 ASCO GU Symposium Saturday

San Francisco, CA - 2011 Genitourinary Cancers Symposium - Brian I. Rini discusses his Abstract #354 Phase III AXIS trial for second-line metastatic renal cell carcinoma (mRCC): Effect of prior first-line treatment duration and axitinib dose titration on axitinib efficacy during the Oral Abstract Session C: Renal Cancer at the 2011 Genitourinary Cancers Symposium (GI) meeting at the Marriott Marquis here today, Saturday February 4, 2012. A record 2500 attendees from around the world were on hand to learn the latest treatment and research in Genitourinary cancers from fellow physicians, researchers, health care professionals, cancer survivors and patient advocates. Photo by © ASCO/Todd Buchanan 2012 Technical Questions: todd@toddbuchanan.com; Phone: 612-226-5154.